ArticlePharmacoEconomics2025

Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.

Micha J Pilz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.